ObvioHealth Introduces ObvioGo 2.2: Transforming Study Management with AI-Driven Innovation
AI-Driven Enhancements in ObvioGo 2.2 Redefine Efficiency, Compliance, and Innovation in Clinical Trial Management NEW YORK, Jan. 14, 2025 /PRNewswire/...
Clinical Trial
Virgo Launches EndoML: A Revolutionary AI Platform Powered by the EndoDINO Foundation Model
Advancing Precision Medicine in Gastroenterology by Leveraging the World's Largest Endoscopy Video Dataset SAN DIEGO, Jan. 14, 2025 /PRNewswire/ -- Virgo,...
Virgo Launches EndoML: A Revolutionary AI Platform Powered by the EndoDINO Foundation Model
Advancing Precision Medicine in Gastroenterology by Leveraging the World's Largest Endoscopy Video Dataset SAN DIEGO, Jan. 14, 2025 /PRNewswire/ -- Virgo,...
Metabolon Appoints Michael Irwin as Vice President, Global Head of Sales
Michael Irwin will drive Metabolon's global sales strategy as the company moves into its next phase of growth in the...
Metabolon Appoints Michael Irwin as Vice President, Global Head of Sales
Michael Irwin will drive Metabolon's global sales strategy as the company moves into its next phase of growth in the...
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Alert Investors to Sanjay Gupta/CNN Program on Ketamine, Featuring Kadima Neuropsychiatry Institute Founder Dr. David Feifel
"'Special K': The Science & Stigma of Ketamine" on CNN, hosted by Dr. Sanjay GuptaDavid Feifel MD PHD, Founder of...
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Alert Investors to Sanjay Gupta/CNN Program on Ketamine, Featuring Kadima Neuropsychiatry Institute Founder Dr. David Feifel
"'Special K': The Science & Stigma of Ketamine" on CNN, hosted by Dr. Sanjay GuptaDavid Feifel MD PHD, Founder of...
BioVaxys Technology Corp. to Present at the Emerging Growth Conference on Thursday January 16, 2025
BioVaxys Technology Corp. invites individual and institutional investors as well as advisors and analysts to attend its real-time, interactive presentation...
BioVaxys Technology Corp. to Present at the Emerging Growth Conference on Thursday January 16, 2025
BioVaxys Technology Corp. invites individual and institutional investors as well as advisors and analysts to attend its real-time, interactive presentation...
AT J.P. MORGAN HEALTHCARE CONFERENCE, 120/80 GROUP PROJECTS ANOTHER YEAR OF RAPID GROWTH IN HELPING TO ACCELERATE THE CONVERGENCE OF AI AND HEALTH
The Consultancy Announces Executive Hires, New Research and Conference Platforms Focused on Life Sciences and AI NEW YORK and SAN...
Trellus Health to Bring Holistic Support to Patients, Working With a Pharmaceutical Company
Trellus Health to Bring Holistic Support to Patients, Working With a Pharmaceutical Company LONDON and NEW YORK, Jan. 14, 2025...
PaxMedica Announces First Patent Allowance for Suramin Intranasal Formulation in the treatment of Autism Spectrum Disorder and Other Conditions
BOSTON, MA / ACCESSWIRE / January 14, 2025 / PaxMedica, Inc. (OTC PINK:PXMD), a clinical-stage biopharmaceutical company dedicated to advancing...
RespondHealth collaborates with Microsoft to advance AI-Powered Real-World Health Intelligence
BETHESDA, Md., Jan. 13, 2025 /PRNewswire/ -- RespondHealth, a real-world evidence (RWE) clinical discovery company, is pleased to announce a new...
Every Cure Expands Collaboration with Google Cloud to Transform AI-Driven Drug Repurposing
Every Cure will leverage Google Cloud's infrastructure and AI technologies, including Gemini 2.0, to accelerate discoveries and improve patient outcomes...
Aignostics Announces Results for Pathology Foundation Model Developed in Collaboration with Mayo Clinic
Model was generated in only two months and sets new industry standard for performance BERLIN and NEW YORK, Jan. 13,...
TheraVac Biologics Partners With Perceiv AI to Optimize Clinical Trials Using Advanced AI and Prognostic Biomarkers
SAN FRANCISCO, CALIFORNIA / ACCESSWIRE / January 13, 2025 / TheraVac Biologics (TheraVac), a company developing innovative immunotherapies for neurological...
EDETEK Unveils Revolutionary Life Sciences R&D Cloud for Clinical Development
Unveiling the next generation paradigm in Clinical Data Sciences PRINCETON, N.J., Jan. 13, 2025 /PRNewswire/ -- EDETEK Inc., a leading global...
Kognitic’s AI Model Revolutionizes Primary Completion Date Predictions for Clinical Trials
A newly published study shows Kognitic's AI reduces clinical trial primary completion date prediction errors from 508 to 179 days,...
Suvoda and Greenphire to Merge Creating a Technology Platform Optimizing Clinical Trial Processes and Streamlining the Patient Journey
CONSHOHOCKEN, Pa. and KING OF PRUSSIA, Pa., Jan. 13, 2025 /PRNewswire/ -- Suvoda, a global clinical trial technology company specializing...
EMA Wellness Bolsters Executive Leadership to Support Growing Global Demand for a Singular Clinical Trial Data, Analytics and Adjudication Platform
New CEO, Chief Business Officer and Executive Advisors bring track records of driving growth and innovation in successful clinical trials...